EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mortalin: Protein partners, biological impacts, pathological roles, and therapeutic opportunities

Niki Esfahanian, Cole D Knoblich, Gaven A Bowman, Khosrow Rezvani

Frontiers in Cell and Developmental Biology · 02.02.2023 · 11

DOI: 10.3389/fcell.2023.1028519 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 02.02.2023. Verfasst von Niki Esfahanian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Basic Biomedical Sciences, Sanford School of Medicine, The University of South Dakota, Vermillion, SD, United States. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of General Medical Sciences, National Cancer Research Institute, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mortalin (GRP75, HSPA9A), a heat shock protein (HSP), regulates a wide range of cellular processes, including cell survival, growth, and metabolism. The regulatory functions of mortalin are mediated through a diverse set of protein partners associated with different cellular compartments, which allows mortalin to perform critical functions under physiological conditions, including mitochondrial protein quality control. However, alteration of mortalin’s activities, its abnormal subcellular compartmentalization, and its protein partners turn mortalin into a disease-driving protein in different pathological conditions, including cancers. Here, mortalin’s contributions to tumorigenic pathways are explained. Pathology information based on mortalin’s RNA expression extracted from The Cancer Genome Atlas (TCGA) transcriptomic database indicates that mortalin has an independent prognostic value in common tumors, including lung, breast, and colorectal cancer (CRC). Subsequently, the binding partners of mortalin reported in different cellular models, from yeast to mammalian cells, and its regulation by post-translational modifications are discussed. Finally, we focus on colorectal cancer and discuss how mortalin and its tumorigenic downstream protein targets are regulated by a ubiquitin-like protein through the 26S proteasomal degradation machinery. A broader understanding of the function of mortalin and its positive and negative regulation in the formation and progression of human diseases, particularly cancer, is essential for developing new strategies to treat a diverse set of human diseases critically associated with dysregulated mortalin.

Schlagwörter

Stichwörter der Autor:innen

cancercellular localizationmortalin (HSPA9)post-translational modification (PTM)protein partners

Autor:innen und Institutionen

  • Division of Basic Biomedical Sciences, Sanford School of Medicine, The University of South Dakota, Vermillion, SD, United States.

Förderung

  • National Institute of General Medical Sciences
  • National Cancer Research Institute
  • National Science Foundation

Zitieren

APA

Esfahanian, N., Knoblich, C. D., Bowman, G. A., & Rezvani, K. (2023). Mortalin: Protein partners, biological impacts, pathological roles, and therapeutic opportunities. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1028519

Vancouver

Esfahanian N, Knoblich CD, Bowman GA, Rezvani K. Mortalin: Protein partners, biological impacts, pathological roles, and therapeutic opportunities. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1028519

BibTeX
@article{Esfahanian2023,
  author = {Esfahanian, Niki and Knoblich, Cole D and Bowman, Gaven A and Rezvani, Khosrow},
  title = {Mortalin: Protein partners, biological impacts, pathological roles, and therapeutic opportunities},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2023},
  volume = {11},
  doi = {10.3389/fcell.2023.1028519}
}
Kostenlos starten →